Work

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Year: 2003

Type: article

Source: PubMed

Authors: Lucio Tentori, Carlo Leonetti, Marco Scarsella, Giulia D'Amati, Matteo Vergati, Ilaria Portarena, Weizheng Xu, Vincent Kalish, Gabriella Zupi, Jie Zhang, Grazia Graziani

Institution: University of Rome Tor Vergata

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2137903987

FWCI: 4.333

Cites: 57

Cited by: 201

Related to: 10